208 related articles for article (PubMed ID: 23649168)
1. CCR4 mediates CCL17 (TARC)-induced migration of human colon cancer cells via RhoA/Rho-kinase signaling.
Al-haidari AA; Syk I; Jirström K; Thorlacius H
Int J Colorectal Dis; 2013 Nov; 28(11):1479-87. PubMed ID: 23649168
[TBL] [Abstract][Full Text] [Related]
2. HMG-CoA reductase regulates CCL17-induced colon cancer cell migration via geranylgeranylation and RhoA activation.
Al-Haidari AA; Syk I; Thorlacius H
Biochem Biophys Res Commun; 2014 Mar; 446(1):68-72. PubMed ID: 24582560
[TBL] [Abstract][Full Text] [Related]
3. MiR-155-5p positively regulates CCL17-induced colon cancer cell migration by targeting RhoA.
Al-Haidari AA; Syk I; Thorlacius H
Oncotarget; 2017 Feb; 8(9):14887-14896. PubMed ID: 28146427
[TBL] [Abstract][Full Text] [Related]
4. [Expression and function of chemokine TARC/CCR4 at fetal-maternal interface in first trimester].
Li CM; Hou L; Zhang H; Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 2013 Jun; 48(6):421-6. PubMed ID: 24103120
[TBL] [Abstract][Full Text] [Related]
5. Numb inhibits migration and promotes proliferation of colon cancer cells via RhoA/ROCK signaling pathway repression.
Yang Y; Li L; He H; Shi M; He L; Liang S; Qi J; Chen W
Exp Cell Res; 2022 Feb; 411(2):113004. PubMed ID: 34990618
[TBL] [Abstract][Full Text] [Related]
6. CCL17 acts as an antitumor chemokine in micromilieu-driven immune skewing.
Li Y; Cao H; Jiang Z; Yan K; Shi J; Wang S; Wang F; Wang W; Li X; Sun N; Liu L; Chen L; Chen Y; Guo R; Song Y
Int Immunopharmacol; 2023 May; 118():110078. PubMed ID: 37001380
[TBL] [Abstract][Full Text] [Related]
7. CCL17/thymus and activation-regulated chemokine induces calcitonin gene-related peptide in human airway epithelial cells through CCR4.
Bonner K; Pease JE; Corrigan CJ; Clark P; Kay AB
J Allergy Clin Immunol; 2013 Oct; 132(4):942-50.e1-3. PubMed ID: 23731651
[TBL] [Abstract][Full Text] [Related]
8. Internalization of CCR4 and inhibition of chemotaxis by K777, a potent and selective CCR4 antagonist.
Sato T; Iwase M; Miyama M; Komai M; Ohshima E; Asai A; Yano H; Miki I
Pharmacology; 2013; 91(5-6):305-13. PubMed ID: 23751403
[TBL] [Abstract][Full Text] [Related]
9. Engagement of two distinct binding domains on CCL17 is required for signaling through CCR4 and establishment of localized inflammatory conditions in the lung.
Santulli-Marotto S; Boakye K; Lacy E; Wu SJ; Luongo J; Kavalkovich K; Coelho A; Hogaboam CM; Ryan M
PLoS One; 2013; 8(12):e81465. PubMed ID: 24339934
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of Th2 chemokine receptors on T cells from atopic and nonatopic asthmatics in response to Der p 1-pulsed dendritic cells.
Maneechotesuwan K; Wongkajornsilp A; Huabprasert S; Kasetsinsombat K; Suthumansami T
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S62-70. PubMed ID: 20364559
[TBL] [Abstract][Full Text] [Related]
11. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
Yao J; Gao P; Xu Y; Li Z
Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
[TBL] [Abstract][Full Text] [Related]
12. The chemokine receptor CCR4 is expressed and associated with a poor prognosis in patients with gastric cancer.
Lee JH; Cho YS; Lee JY; Kook MC; Park JW; Nam BH; Bae JM
Ann Surg; 2009 Jun; 249(6):933-41. PubMed ID: 19474687
[TBL] [Abstract][Full Text] [Related]
13. Foxp3
Maeda S; Nakazawa M; Uchida M; Yoshitake R; Nakagawa T; Nishimura R; Miyamoto R; Bonkobara M; Yonezawa T; Momoi Y
Vet Pathol; 2020 Jul; 57(4):497-506. PubMed ID: 32347186
[TBL] [Abstract][Full Text] [Related]
14. CCL17 and CCL22 induce CCR4 receptor expression and promote cytokine-induced killer cells migration.
Dong Y; Gao S; Zhang X; Kou J; Liu J; Ye T; Shen H
Anticancer Drugs; 2022 Feb; 33(2):149-157. PubMed ID: 34657098
[TBL] [Abstract][Full Text] [Related]
15. Furin-dependent CCL17-fused recombinant toxin controls HTLV-1 infection by targeting and eliminating infected CCR4-expressing cells in vitro and in vivo.
Hiyoshi M; Okuma K; Tateyama S; Takizawa K; Saito M; Kuramitsu M; Araki K; Morishita K; Okada S; Yamamoto N; Biragyn A; Yamaguchi K; Hamaguchi I
Retrovirology; 2015 Aug; 12():73. PubMed ID: 26289727
[TBL] [Abstract][Full Text] [Related]
16. Potential roles of the CCL17-CCR4 axis in immunopathogenesis of oral lichen planus.
Shan J; Shen C; Fang J; Li S; Fan Y
J Oral Pathol Med; 2020 Apr; 49(4):328-334. PubMed ID: 31322295
[TBL] [Abstract][Full Text] [Related]
17. ERK/STAT3 activation through CCL17/CCR4 axis-mediated type 2 cytokine-involved signaling pathways in Th2 cells regulates cutaneous drug reactions.
Tang JT; Gao KC; Zhang Y; Zhou XY; Yang LH; Kuang YQ; Li YY
Int Immunopharmacol; 2024 Mar; 130():111712. PubMed ID: 38377858
[TBL] [Abstract][Full Text] [Related]
18. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
Li JY; Ou ZL; Yu SJ; Gu XL; Yang C; Chen AX; Di GH; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Feb; 131(3):837-48. PubMed ID: 21479551
[TBL] [Abstract][Full Text] [Related]
19. Gα13/PDZ-RhoGEF/RhoA signaling is essential for gastrin-releasing peptide receptor-mediated colon cancer cell migration.
Patel M; Kawano T; Suzuki N; Hamakubo T; Karginov AV; Kozasa T
Mol Pharmacol; 2014 Sep; 86(3):252-62. PubMed ID: 24958816
[TBL] [Abstract][Full Text] [Related]
20. CCR4 is a determinant of melanoma brain metastasis.
Klein A; Sagi-Assif O; Meshel T; Telerman A; Izraely S; Ben-Menachem S; Bayry J; Marzese DM; Ohe S; Hoon DSB; Erez N; Witz IP
Oncotarget; 2017 May; 8(19):31079-31091. PubMed ID: 28415693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]